03/13/2025
We were on the phone all day yesterday talking to members of Congress why this funding is so important. These cuts will have a significant impact on cancer research. We will continue fighting on behalf of all those affected by cancer.
Last night the House voted to cut 57% of federally funded medical and cancer research through the Department of Defense's Congressionally Directed Medical Research Programs (CDMRP). Currently, the CDMRP funds $50 million in kidney cancer research annually.
“Yesterday the House voted to cut by 57% medical research funded by the Congressionally Directed Medical Research Program (CDMRP), which seeks to improve the health and quality of life of the men and women who serve in the U.S. Armed Services, as well as their families, veterans and military retirees,” said Mark Vieth, Senior VP at CRD Associates and coordinator for the Defense Health Research Consortium, of which KCA is a member. “Since the program was founded in 1992, it has never been cut this severely. This was the worst vote in the history of CDMRP! March 11, 2025 will now be remembered as the “Pearl Harbor Day” for CDMRP.”
According to the CDMRP, if the CR becomes law, they would reduce programs by equal proportions to meet the reduced budget of $650 million. They would plan to proceed in the most fiscally responsible way to minimize management costs and maximize dollars for research programs, and additional program-level information for fiscal year 2025 will be communicated as soon as possible.
The CR goes to senate on Friday for a vote and, if passed, to the President’s office to be signed into law.
The KCA continues to advocate on your behalf to our contacts on the senate floor.
Follow for continued updates: https://www.kidneycancer.org/protect-federal-kidney-cancer-research-funding/
